Merck & Co. Inc.’s stock MRK rose 2% premarket Thursday, after the company posted better-than-expected first-quarter earnings and offered guidance that topped estimates. Rahway, N.J.-based Merck posted net income of $2.821 billion, or $1.11 a share, for the quarter, down from $4.310 billion, or $1.70 a share, in the year-earlier period. Adjusted per-share earnings came to $1.40, ahead of the $1.32 FactSet consensus. Sales fell 9% to $14.487 billion from $15.
-based Merck posted net income of $2.821 billion, or $1.11 a share, for the quarter, down from $4.310 billion, or $1.70 a share, in the year-earlier period. Adjusted per-share earnings came to $1.40, ahead of the $1.32 FactSet consensus. Sales fell 9% to $14.487 billion from $15.901 billion, also ahead of the $13.793 billion FactSet consensus. The profit decline was due to 52 cents of charges related to the acquisition of Imago BioSciences Inc.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »